35:00
Mastologia
BBN ESMO BREAST – 2025 SELECTION
Podcast
30/10/2025
05:00
Português
Ninety Days of Preoperative Endocrine Therapy Informs Patientand Physician Preference for Radiation Therapy: Primary Resultsfrom the Preoperative Window of Endocrine Therapy to InformRadiation Therapy Decisions (POWER) Trial
Postmastectomy Radiation Therapy: An ASTRO-ASCO-SSOClinical Practice Guideline
37:10
Mastologia
POWER TRIAL: Terapia Endócrina Pré-operatória como fator decisório no descalonamento do tratamento da paciente Luminal A, 65anos + e GUIDELINE ASTRO-ASCO-SSO de RT pós mastectomia
Podcast
23/10/2025
05:00
Português
Real-world progression-free survival of CDK4/6 inhibitors plus anaromatase inhibitor in HR-positive/HER2-negative metastatic breast cancerin United States routine clinical practice
Real‑World Application of Alliance ACOSOG Z11102: HowMany Patients Can be Spared Mastectomy?
35:34
Mastologia
ACOSOG 11102 NO MUNDO REAL: QUANTAS PACIENTES PODERIAM EVITAR UMA MASTECTOMIA? e Eficácia Comparativa de Inibidores CDK4/6: Evidências do Mundo Real no Tratamento do Câncer de Mama Metastático
Podcast
16/10/2025
05:00
Português
Mastologia
PET CT FAPI x PET CT FDG: QUEM É O MELHOR?
Podcast
09/10/2025
05:00
Português
The association between young age atmetastatic breast cancer diagnosis andoverall survival in the EMBRACE study
GLP-1 Receptor Agonists and Cancer Risk in Adults With Obesity
29:09
Mastologia
Risco de Câncer entre usuários de Tirzepatida, Semaglutida , Liraglutida e Dulaglutida e Câncer de Mama Metastático: A Influência da Idade no Prognóstico
Podcast
02/10/2025
05:00
Português
Impact of Anthracyclines in Genomic High Risk, Node-Negative, HR-Positive/HER2-Negative Breast Cancer





